Alpha HPA Limited (ASX:A4N)

CTI BioPharma Revenue

Alpha HPA had revenue of 71.07K AUD in the half year ending December 31, 2024, with 726.84% growth. This brings the company's revenue in the last twelve months to 89.86K, up 173.87% year-over-year. In the fiscal year ending June 30, 2024, Alpha HPA had annual revenue of 44.06K with 172.82% growth.

• Revenue (ttm): 89.86K
• Revenue Growth: +173.87%
• P/S Ratio: 11,071.04
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 994.88M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	44.06K	27.91K	172.82%
Jun 30, 2023	16.15K	-22.59K	-58.32%
Jun 30, 2022	38.74K	-	-
Jun 30, 2021	-	-	-
Jun 30, 2020	-	-	-